Average portfolio weight of all funds dedicated to AKRO is 0.19%, an increase of 2.10%. Total shares owned by institutions increased in the last three months by 1.45% to 85,540K shares.

Philadelphia, Pennsylvania--(Newsfile Corp. - December 30, 2024) - If you have held Akero Therapeutics, Inc. (NASDAQ: AKRO) shares since prior to September 13, 2022, you can seek corporate reforms ...

Timothy Rolph, the Chief Scientific Officer of $AKRO ($AKRO), sold 2,450 shares of the company on 12-10-2024. We received data on the trade from a recent SEC filing ...